Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Oral Availability of Cefadroxil Depends on ABCC3 and ABCC4

Dirk R. de Waart, Koen van de Wetering, Cindy Kunne, Suzanne Duijst, Coen C. Paulusma and Ronald P. J. Oude Elferink
Drug Metabolism and Disposition March 2012, 40 (3) 515-521; DOI: https://doi.org/10.1124/dmd.111.041731
Dirk R. de Waart
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Koen van de Wetering
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cindy Kunne
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Suzanne Duijst
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Coen C. Paulusma
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ronald P. J. Oude Elferink
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

Article Information

vol. 40 no. 3 515-521
DOI 
https://doi.org/10.1124/dmd.111.041731
PubMed 
22166395

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received July 11, 2011
  • Accepted December 13, 2011
  • Published online February 15, 2012.

Article Versions

  • Earlier version (December 13, 2011 - 07:37).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2012 by The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Dirk R. de Waart,
  2. Koen van de Wetering,
  3. Cindy Kunne,
  4. Suzanne Duijst,
  5. Coen C. Paulusma and
  6. Ronald P. J. Oude Elferink
  1. AMC Tytgat Institute, Academic Medical Center, Amsterdam, The Netherlands (D.R.d.W., C.K., S.D., C.C.P., R.P.J.O.); and Division of Molecular Biology, The Netherlands Cancer Institute, Amsterdam, The Netherlands (K.v.d.W.)
  1. Address correspondence to:
    Dirk R. de Waart, AMC Tytgat Institute, Meibergdreef 69-71, 1105 BK Amsterdam, The Netherlands. E-mail: d.r.dewaart{at}amc.uva.nl
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2017 to August 2022

AbstractFullPdf
Aug 201711016
Sep 201702022
Oct 201711423
Nov 201701515
Dec 20170612
Jan 201821314
Feb 201812522
Mar 201811611
Apr 2018110929
May 201806923
Jun 2018310030
Jul 201814824
Aug 201822111
Sep 20180244
Oct 201805415
Nov 201816615
Dec 201849117
Jan 20196928
Feb 20194004
Mar 201928212
Apr 20191307
May 20191215
Jun 20191916
Jul 20191227
Aug 20191805
Oct 20191402
Nov 20193221
Dec 20192623
Jan 20201723
Feb 2020820
Mar 20201835
May 20201042
Jun 20201000
Jul 20201021
Aug 2020426
Sep 20201752
Oct 20202813
Nov 20202624
Dec 20201504
Jan 20211824
Feb 20212634
Mar 20212755
Apr 20212641
May 20214510
Jun 20213510
Jul 20215431
Aug 20212411
Sep 20212233
Oct 20211513
Nov 20212426
Dec 20212412
Jan 20221211
Feb 2022921
Mar 20221840
Apr 20222155
May 20222011
Jun 20222923
Jul 202218323
Aug 2022800

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 40 (3)
Drug Metabolism and Disposition
Vol. 40, Issue 3
1 Mar 2012
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Oral Availability of Cefadroxil Depends on ABCC3 and ABCC4
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

TRANSPORT OF CEFADROXILBY ABCC3 AND ABCC4

Dirk R. de Waart, Koen van de Wetering, Cindy Kunne, Suzanne Duijst, Coen C. Paulusma and Ronald P. J. Oude Elferink
Drug Metabolism and Disposition March 1, 2012, 40 (3) 515-521; DOI: https://doi.org/10.1124/dmd.111.041731

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

TRANSPORT OF CEFADROXILBY ABCC3 AND ABCC4

Dirk R. de Waart, Koen van de Wetering, Cindy Kunne, Suzanne Duijst, Coen C. Paulusma and Ronald P. J. Oude Elferink
Drug Metabolism and Disposition March 1, 2012, 40 (3) 515-521; DOI: https://doi.org/10.1124/dmd.111.041731
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Authorship Contributions
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Human ADME Properties of Abrocitinib
  • MSCs Pharmacokinetics under liver diseases
  • In Vitro P450 Suppression by Peptide Not Observed in Clinic
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics